Boston Scientific Corporation BSX NYSE

Boston Scientific Corporation (BSX) 报告总资产为 $43.67B 总负债为 $19.2B 財年 2025, 总权益为 $24.47B.

公司持有 $2.05B 现金及短期投资. 总债务为 $12.42B, 净债务为 $10.37B. D/E比率为 0.51 (适中的).

流动比率为 1.62, 表明短期流动性强. 利息覆蓋率为 11.4x (强劲的).

本页支持的标准:

• HEALTH (83/100, Pass) — Debt-to-Equity of 0.51, current ratio of 1.62, interest coverage 11.4x — 资产负债表强劲
• MOAT (80/100) — 总资产 $43.67B 和 equity $24.47B 支持公司的竞争规模
• VALUE (51/100) — Debt-to-Equity 0.51 影响整体估值风险评估

SharesGrow 收入评分: 80/100 其中 5/7 项标准通过.

AMGN

Amgen Inc.

$350.95

+0.32%

ABT

Abbott Laboratories

$101.07

+0.38%

GILD

Gilead Sciences, Inc.

$140.45

+1.02%

PFE

Pfizer Inc.

$27.13

-0.77%

DHR

Danaher Corporation

$198.61

+1.40%

SYK

Stryker Corporation

$345.88

-0.39%

SNY

Sanofi

$47.64

+1.45%

MDT

Medtronic plc

$88.12

+0.14%